19 June 2013
Keywords: new, erbitux, results, add, imclone, woes, astrazeneca
Article | 27 May 2002
While AstraZeneca has much to feel positive about with its Iressa drug(see story alongside), there was worse news at ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 May 2002
10 June 2002
18 June 2013
© 2013 thepharmaletter.com